imatinib mesylate has been researched along with Diffuse Tenosynovial Giant Cell Tumor in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blay, JY; Cassier, P; Dufresne, A; Heudel, P; Pissaloux, D; Ray-Coquard, I; Wang, Q | 1 |
| Bai, XZ; Chen, K; Han, XR; Ren, Q; Wei, B; Zhang, XN | 1 |
| Lewis, VO; Ravi, V; Wang, WL | 1 |
| Blay, JY; Bompas, E; Cassier, PA; Dômont, J; Gelderblom, H; Italiano, A; Kroep, JR; Maki, RG; Seddon, B; Stacchiotti, S; Thomas, D; van der Graaf, WT; Wagner, AJ | 1 |
| Temple, HT | 1 |
| Blay, JY; El Sayadi, H; Garret, J; Ray-Coquard, I; Thiesse, P | 1 |
3 review(s) available for imatinib mesylate and Diffuse Tenosynovial Giant Cell Tumor
| Article | Year |
|---|---|
[Molecular biology of sarcoma and therapeutic choices].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Benzamides; Bone Neoplasms; Crizotinib; Denosumab; Dermatofibrosarcoma; Gastrointestinal Stromal Tumors; Gene Amplification; Gene Deletion; Giant Cell Tumor of Bone; Humans; Imatinib Mesylate; Indoles; Molecular Targeted Therapy; Phenylurea Compounds; Piperazines; Point Mutation; Prognosis; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Sarcoma; Sarcoma, Ewing; Sunitinib; Synovitis, Pigmented Villonodular; Translocation, Genetic | 2015 |
Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis.
Topics: Antineoplastic Agents; Benzamides; Giant Cell Tumors; Humans; Imatinib Mesylate; Indoles; Macrophage Colony-Stimulating Factor; Macrophages; Piperazines; Pyrimidines; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Soft Tissue Neoplasms; Sunitinib; Synovial Membrane; Synovitis, Pigmented Villonodular; Tendons | 2011 |
Pigmented villonodular synovitis therapy with MSCF-1 inhibitors.
Topics: Antibodies, Monoclonal; Benzamides; Humans; Imatinib Mesylate; Macrophage Colony-Stimulating Factor; Piperazines; Pyrimidines; Receptor, Macrophage Colony-Stimulating Factor; Synovitis, Pigmented Villonodular | 2012 |
3 other study(ies) available for imatinib mesylate and Diffuse Tenosynovial Giant Cell Tumor
| Article | Year |
|---|---|
Imatinib mesylate induces mitochondria-dependent apoptosis and inhibits invasion of human pigmented villonodular synovitis fibroblast-like synovial cells.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 9; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Mitochondria; Synovitis, Pigmented Villonodular; Tumor Cells, Cultured | 2016 |
Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Female; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Metastasis; Piperazines; Pyrimidines; Receptor, Macrophage Colony-Stimulating Factor; Retrospective Studies; Synovitis, Pigmented Villonodular | 2012 |
Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT).
Topics: Adult; Antineoplastic Agents; Benzamides; Elbow Joint; Female; Giant Cell Tumors; Humans; Imatinib Mesylate; Joint Diseases; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Synovitis, Pigmented Villonodular; Treatment Outcome | 2008 |